News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
847,263 Results
Type
Article (86513)
Company Profile (702)
Press Release (760048)
Multimedia
Podcasts (131)
Webinars (14)
Section
Business (232694)
Career Advice (4128)
Deals (39721)
Drug Delivery (129)
Drug Development (90987)
Employer Resources (198)
FDA (18113)
Job Trends (17338)
News (396482)
Policy (39749)
Tag
Academia (3000)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (96)
Alliances (56841)
ALS (104)
Alzheimer's disease (1505)
Antibody-drug conjugate (ADC) (164)
Approvals (18069)
Artificial intelligence (334)
Autoimmune disease (30)
Automation (16)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (120)
Biotechnology (481)
Bladder cancer (85)
Brain cancer (32)
Breast cancer (314)
Cancer (2490)
Cardiovascular disease (210)
Career advice (3535)
Career pathing (34)
CAR-T (176)
Cell therapy (501)
Cervical cancer (22)
Clinical research (73480)
Collaboration (934)
Company closure (2)
Compensation (578)
Complete response letters (30)
COVID-19 (2869)
CRISPR (50)
C-suite (275)
Cystic fibrosis (109)
Data (2365)
Decentralized trials (2)
Denatured (46)
Depression (57)
Diabetes (303)
Diagnostics (6930)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (152)
Drug pricing (130)
Drug shortages (33)
Duchenne muscular dystrophy (104)
Earnings (97016)
Editorial (45)
Employer branding (25)
Employer resources (167)
Events (130235)
Executive appointments (787)
FDA (19545)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (834)
Gene editing (125)
Generative AI (35)
Gene therapy (366)
GLP-1 (862)
Government (5170)
Grass and pollen (6)
Guidances (150)
Healthcare (20890)
Huntington's disease (26)
IgA nephropathy (31)
Immunology and inflammation (152)
Indications (30)
Infectious disease (3033)
Inflammatory bowel disease (159)
Inflation Reduction Act (11)
Influenza (59)
Intellectual property (102)
Interviews (813)
IPO (17830)
IRA (51)
Job creations (5190)
Job search strategy (2861)
Kidney cancer (11)
Labor market (46)
Layoffs (564)
Leadership (24)
Legal (10114)
Liver cancer (82)
Lung cancer (349)
Lymphoma (161)
Machine learning (9)
Management (65)
Manufacturing (372)
MASH (81)
Medical device (14644)
Medtech (14649)
Mergers & acquisitions (22456)
Metabolic disorders (808)
Multiple sclerosis (89)
NASH (23)
Neurodegenerative disease (117)
Neuropsychiatric disorders (34)
Neuroscience (2124)
NextGen: Class of 2025 (7682)
Non-profit (5082)
Now hiring (41)
Obesity (433)
Opinion (275)
Ovarian cancer (83)
Pain (105)
Pancreatic cancer (91)
Parkinson's disease (163)
Partnered (24)
Patents (258)
Patient recruitment (119)
Peanut (51)
People (65338)
Pharmaceutical (143)
Pharmacy benefit managers (22)
Phase I (22672)
Phase II (31909)
Phase III (24035)
Pipeline (1397)
Policy (180)
Postmarket research (3552)
Preclinical (10235)
Press Release (72)
Prostate cancer (114)
Psychedelics (38)
Radiopharmaceuticals (270)
Rare diseases (437)
Real estate (7392)
Recruiting (75)
Regulatory (26835)
Reports (58)
Research institute (2658)
Resumes & cover letters (649)
Rett syndrome (5)
RNA editing (5)
RSV (50)
Schizophrenia (82)
Series A (144)
Series B (94)
Service/supplier (30)
Sickle cell disease (59)
Special edition (19)
Spinal muscular atrophy (166)
Sponsored (34)
Startups (4294)
State (2)
Stomach cancer (16)
Supply chain (76)
Tariffs (53)
The Weekly (83)
Vaccines (823)
Venture capitalists (45)
Weight loss (306)
Women's health (40)
Worklife (20)
Date
Today (187)
Last 7 days (994)
Last 30 days (3275)
Last 365 days (35610)
2025 (12802)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (61)
Alaska (7)
Arizona (270)
Arkansas (14)
Asia (50168)
Australia (8835)
California (6682)
Canada (2106)
China (574)
Colorado (289)
Connecticut (307)
Delaware (168)
Europe (115117)
Florida (976)
Georgia (226)
Hawaii (1)
Idaho (64)
Illinois (641)
India (31)
Indiana (343)
Iowa (12)
Japan (178)
Kansas (113)
Kentucky (28)
Louisiana (15)
Maine (70)
Maryland (993)
Massachusetts (5107)
Michigan (252)
Minnesota (432)
Mississippi (2)
Missouri (92)
Montana (31)
Nebraska (26)
Nevada (69)
New Hampshire (70)
New Jersey (1875)
New Mexico (31)
New York (1876)
North Carolina (1149)
North Dakota (9)
Northern California (2875)
Ohio (224)
Oklahoma (15)
Oregon (48)
Pennsylvania (1464)
Puerto Rico (14)
Rhode Island (36)
South America (1653)
South Carolina (26)
South Dakota (1)
Southern California (2482)
Tennessee (108)
Texas (1005)
United States (25523)
Utah (199)
Virginia (177)
Washington D.C. (72)
Washington State (615)
West Virginia (3)
Wisconsin (72)
There are 847,263 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Neural Therapeutics Announces SERFOR Permit Renewal Submission and Extension of LOI with HANF.COM
May 9, 2025
·
8 min read
Press Releases
Kiora Pharmaceuticals Reports First Quarter Results; Initiating Two Phase 2 Trials for Treatment of Retinal Diseases; Cash and Short-term Investments Expected to Fund Operations into Late 2027
May 9, 2025
·
10 min read
Layoff Tracker
Shape, Vor Cut Workforces
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
May 9, 2025
·
197 min read
·
BioSpace Editorial Staff
Press Releases
BioDlink Applauds Junshi Biosciences on IND Approval of Bispecific ADC Candidate JS212
May 9, 2025
·
1 min read
Layoffs
Sanofi Cuts Off Antibody Partner, Forcing 80% Headcount Reduction at IGM
After losing its powerhouse partner, IGM Biosciences closed “most” of its labs and offices and initiated a strategic review of potential strategic alternatives and options for the business.
May 9, 2025
·
2 min read
·
Tristan Manalac
Artificial intelligence
Amid Layoffs, Delays, FDA Turns to AI for Speedy Reviews
The FDA expects to fully integrate its AI approach by June 30, though its different centers have been instructed to start the rollout immediately.
May 9, 2025
·
2 min read
·
Tristan Manalac
Regulatory
FDA Delays Continue as Regulator Misses Review Date for GSK’s Nucala
The missed PDUFA adds to a string of delays at the FDA in recent weeks, including at least two other missed target action dates.
May 9, 2025
·
2 min read
·
Tristan Manalac
Layoffs
Rallybio Downsizes by 40% After Dropping Lead Asset
The company discontinued development last month of its most mature asset, RLYB212, following disappointing mid-stage pharmacokinetic findings in a rare bleeding disorder.
May 9, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Akero Therapeutics Presents Week 96 Results from Phase 2b SYMMETRY Clinical Trial of Efruxifermin in Patients with Compensated Cirrhosis Caused by MASH Showing Fibrosis Improvement without Worsening of MASH at the EASL Congress 2025
May 9, 2025
·
8 min read
Press Releases
Sanuwave Announces Q1 FY2025 Financial Results
May 9, 2025
·
13 min read
1 of 84,727
Next
